A one-off injection could one day lower your cholesterol levels for the rest of your life (New Scientist, 2017). People born with natural mutations which disable a specific gene have a lower risk of heart disease, with no apparent side effects. Now a single injection has successfully disabled this gene in animal tests for the … Continue reading Injection could permanently lower cholesterol by changing your DNA

BBI Group has today announced the completion of its acquisition by Exponent Private Equity (MediWales, 2017). Commenting on the deal, BBI Group CEO Lyn Rees said “This acquisition represents a firm commitment to the future growth plan of BBI, with the new ownership backed by a proven track record in the investment of resources for … Continue reading BBI Group acquired by Exponent Private Equity

Proton Partners International, which is currently developing cancer treatment centres in Newport, Northumberland and Reading, has made two appointments to its senior executive team (Business Insider, 2017). Dr Ian Barwick, the former COO of the Life Sciences Hub Wales, is company’s new chief scientific officer. He will play an integral role in patient-led research. Lis … Continue reading Proton Partners make two senior appointments

A male contraceptive gel has been found to work reliably in a trial in primates, bringing the prospect of an alternative form of birth control for humans closer (The Guardian, 2017). The product, called Vasalgel, is designed to be a reversible and less invasive form of vasectomy and in the latest study was 100% effective … Continue reading Male contraceptive gel 100% effective in trial with monkeys

BBI Group is consolidating and expanding its UK manufacturing operations onto a single site in Caerphilly in an £8.5m investment, supported by the Welsh Government, that will create and safeguard more than three hundred and sixty jobs in Wales (Welsh Government, 2017). BBI Group, which is currently headquartered in Cardiff, has a number of manufacturing … Continue reading BBI Group and the Welsh Government announce multi-million pound investment

Signum Health, a Caerphilly-based digital referral platform for medical professionals, healthcare providers and the public, has secured a six figure equity co-investment from Finance Wales and four angel investors (MediWales, 2017). As well as Finance Wales, investment comes from William Record, owner of Welsh ICE, investment specialist and CEO of Cognis Capital Myra Tabor, former … Continue reading Signum Health secures six figure investment

Alesi Surgical has secured FDA approval for its Ultravision system (MediWales, 2017). The Ultravision system clears the vapour and particulate matter generated by modern surgical cutting instruments during laparoscopic surgery through the use of electrostatic technology. The technology dramatically and effortlessly improves visibility for surgeons that is otherwise rapidly obscured by surgical smoke. Dr Dominic … Continue reading Alesi Surgical gains FDA approval for Ultravision

Magstim has launched INSIGHT, the first cloud-based electronic health record management solution for TMS practices (Mediwales, 2017). Magstim INSIGHT is a convenient and mobile platform created to securely store patient and TMS treatment information. American TMS providers will be able to share data remotely with co-workers, track patients’ progress and chart their treatment outcomes. It … Continue reading Magstim launches health record management solution

IBA, Royal Philips and Proton Partners International have announced that they will be collaborating to build the first compact proton therapy system in the Middle East (MediWales, 2017). The proton therapy centre will be part of a large existing hospital, the Gulf International Cancer Center. The proton therapy centre will be the first compact proton … Continue reading Proton Partners, IBA and Philips Join Forces in Cancer Care in the Middle East

MedaPhor Group has announced that it has now formalised and executed their agreement on a patent licence and patent infringement settlement with SonoSim Inc. and The Regents of the University of California (MedaPhor, 2017). As a result, the lawsuit between the parties will be dismissed with prejudice. MedaPhor’s unaudited group turnover for the year to … Continue reading MedaPhor and SonoSim settle patent infringement